Oral equipment maker Panthera Dental and sleep diagnostic and therapy enterprise ResMed have arrived at a settlement resolving patent infringement litigation around ResMed’s Narval CC nylon oral appliance for rest apnea.
“We are delighted to announce that we have reached an amicable settlement with ResMed SAS that resolves all ongoing patent infringement litigation concerning Panthera and ResMed SAS in relation to our mandibular repositioning equipment,” says Gabriel Robichaud, CEO of Panthera Dental, in a launch. “We are very pleased with this agreement, which signifies a optimistic result for Panthera.”
Intellectual home is a critical part of the innovation that drives Panthera’s strategic development, Robichaud says, incorporating that this settlement is an important phase in the company’s business growth.
ResMed spokesperson Brad Lotterman suggests in an emailed statement, “We are happy that patent litigation with Panthera, involving ResMed patents safeguarding our Narval product or service in Europe, has been amicably fixed by the parties by means of a private out of courtroom settlement. With 35 years of innovation and extra than 9,500 pending or issued patents and styles, ResMed is a leader in snooze remedy. We will defend our improvements to make certain patients continue on to obtain the higher-top quality treatment they hope from us.”
In 2018, Narval CC was discontinued in the US current market.
Photo: Panthera Dental oral appliances
Leave a Reply